GLP-1 Agonists Associated with Doubled Risk of Neovascular AMD, Study Finds
Blockbuster meds, blockbuster risks? Trending GLP-1s (like Ozempic) are now raising red flags for nAMD. A new population-based cohort study…
Back with a Roar!: The European VitreoRetinal Society is back after a three-year hiatus
The coveted vitreoretinal conference took place from August 31 to September 3 in Cappadocia, Turkey, and was attended by over…
popular posts
latest posts